Dearborn Partners LLC Acquires New Holdings in Proto Labs, Inc. $PRLB

Dearborn Partners LLC bought a new position in Proto Labs, Inc. (NYSE:PRLBFree Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 217,223 shares of the industrial products company’s stock, valued at approximately $22,302,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Royal Bank of Canada raised its stake in Proto Labs by 51.3% during the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock worth $228,000 after buying an additional 2,207 shares during the period. AQR Capital Management LLC increased its holdings in shares of Proto Labs by 3.3% in the first quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock worth $2,238,000 after acquiring an additional 2,040 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Proto Labs by 7,380.0% during the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 738 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Proto Labs by 68.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock valued at $871,000 after purchasing an additional 8,864 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in shares of Proto Labs in the 2nd quarter valued at approximately $480,000. Institutional investors and hedge funds own 84.54% of the company’s stock.

Proto Labs Price Performance

Shares of NYSE PRLB opened at $76.55 on Tuesday. The business has a 50-day moving average of $80.52 and a 200-day moving average of $70.47. The stock has a market capitalization of $1.83 billion, a price-to-earnings ratio of 61.24 and a beta of 1.40. Proto Labs, Inc. has a fifty-two week low of $45.10 and a fifty-two week high of $93.00.

Proto Labs (NYSE:PRLBGet Free Report) last issued its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.53 by $0.07. The firm had revenue of $149.34 million during the quarter, compared to analysts’ expectations of $144.53 million. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The business’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, sell-side analysts expect that Proto Labs, Inc. will post 1.46 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on PRLB. Weiss Ratings lowered shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, August 18th. Wall Street Zen cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. Needham & Company LLC upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 target price for the company in a report on Monday, August 3rd. Zacks Research raised Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. Finally, Benchmark upped their price objective on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $89.00.

Check Out Our Latest Stock Analysis on PRLB

Insider Transactions at Proto Labs

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the sale, the director owned 32,505 shares in the company, valued at $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.30% of the company’s stock.

Proto Labs Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

See Also

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLBFree Report).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.